← Back
Research and new methods

Generations of CAR-T: engineered T cells

CAR-T means taking a patient's own T cells, giving them a receptor in the laboratory that recognises a cancer marker (for example CD19), and returning them. Each generation improves the receptor's design.

Last updated: ~1 min read
A human T cell in false colour under a scanning electron microscope
Figure 1.A T cell — the starting material for CAR-T

01Short answer

The first generation had only a recognition signal and did not last long in the body. The second generation added a co-stimulation signal (for example CD28 or 4-1BB), which improved how the cells multiply and persist; today's approved products are mostly of this kind. Later generations add several signals, two targets or helper substances and are still in trials. CAR-T is used in B-ALL and some lymphomas; the main risks are CRS and neurotoxicity.

02Simple explanation

Your own T cells.

A receptor is added.

Second generation: standard.

Newer ones: in trials.

03Scientific explanation

NCI: CAR T-cell therapy changes a patient's T cells so that they attack cancer cells.

NCI: new treatments are tested step by step, from the laboratory to clinical trials; only those proven safe and beneficial become standard care.

04What happens in the body?

Co-stimulation

A second signal that strengthens the T cell.

Generations
Figure 2.Generations — Generations of CAR-T: engineered T cells

Persistence

How long CAR-T cells remain in the body.

Multiplying
Figure 3.Multiplying — Generations of CAR-T: engineered T cells

How to read the news

Research news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.

Talk to your doctor

Show your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

05From research news to a conversation: four steps

Read, check, ask, decide together.

Read — From a trusted source.1ReadFrom a trusted source.
Check — Phase, participants, result.2CheckPhase, participants, result.
Ask — Show your doctor.3AskShow your doctor.
Decide — Together, without rushing.4DecideTogether, without rushing.
SourceA trusted site.
DoctorA personal explanation.
SafetyNot changing treatment yourself.

06Key points at a glance

TopicIn brief
Co-stimulationA second signal that strengthens the T cell.
PersistenceHow long CAR-T cells remain in the body.
How to read the newsResearch news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.
Talk to your doctorShow your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

07Key terms

CAR
Chimeric antigen receptor.
Apheresis
Collecting certain cells from the blood.
Clinical trial
Testing a new treatment with volunteers.
Evidence
A result confirmed by reliable research.

08Key points

  • Collect.
  • Engineer.
  • Return.
  • Check the source.
  • Talk to your doctor.

09Frequently asked questions

Who receives CAR-T?

Usually people with relapsed or resistant B-ALL under certain conditions; your doctor assesses this.

How long does manufacturing take?

Often a few weeks.

Is this advance right for me?

Only your treating doctor can say, based on your diagnosis, stage and condition.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

  1. Who receives CAR-T?

  2. How long does manufacturing take?

  3. Is this advance right for me?

My questions

12Sources

  1. National Cancer Institute. CAR T Cells: Engineering Immune Cells to Treat Cancer
  2. National Cancer Institute. Immunotherapy to Treat Cancer
  3. National Cancer Institute. What Are Clinical Trials?
  4. National Cancer Institute. Phases of Clinical Trials
  5. National Cancer Institute. Using Trusted Resources
  6. National Cancer Institute. Placebos in Cancer Clinical Trials
  7. National Cancer Institute. NCI Dictionary of Cancer Terms: control group
  8. National Cancer Institute. Randomization in Clinical Trials
  9. National Cancer Institute. NCI Dictionary of Cancer Terms: randomized clinical trial
  10. National Cancer Institute. NCI Dictionary of Cancer Terms: overall survival
Medical disclaimerThis information is for educational purposes only and does not replace medical advice.
Last updated: ← Back to the list

Open the interactive site →